Stockreport

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Nautilus Biotechnology, Inc.  (NAUT) 
PDF SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platfo [Read more]